2022
DOI: 10.17816/vto99996
|View full text |Cite
|
Sign up to set email alerts
|

The first experience of using the biocomposite material "Osteomatrix" in the clinic of bone pathology

Abstract: At CITO Clinic of bone pathology new biocomposite material Osteomatrix was used in 15 patients (mainly with tumors and tumor-like diseases) for the plasty of post-resection bone defects. Osteomatrix is composed of bone collagen, hydroxyapatite and sulfated glycosaminoglycanes. Osteomatrix is produced at CITO together with Conectbiopharm Ltd. in the form of granules and blocks. Observation in dynamics with roentgenologic control showed good tolerance of Osteomatrix by patients and distinct accelerated bone rege… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 0 publications
0
0
0
Order By: Relevance